Cloud Banner

Pharmaceutical

Image

Europe Medical Cannabis Market – Industry Trends and Forecast to 2031

  • Pharmaceutical
  • Published Report
  • Jan 2024
  • Europe
  • 350 Pages
  • No of Tables: 460
  • No of Figures: 24

Europe Medical Cannabis Market, By Product (Oil, Dried Medial Cannabis, Medical Cannabis Capsules, Whole Flower, Ground Flower, Vape Pen, Creams & Moisturizer, and Others), Source (Synthetic and Natural), Species (Cannabis Indica, Sativa, and Hybrid), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC) /Delta-8-Tetrahydrocannabinol, and Others), Application (Pain Management, Anxiety, Muscle Spasms, Nausea, Appetite Loss, Cancer, Arthritis, Alzheimer's Disease/Migranes, Epilepsy, Depression and Sleep Disorders, Multiple Sclerosis, Autism, Mental Health Conditions, Elevate Mood, and Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others), End User (Pharmaceutical Industry, Research and Development Centers, Homecare Setting, Hospital, Rehab Centers, and Others), Distribution Channel (B2B and B2C) - Industry Trends and Forecast to 2031.

Europe Medical cannabis Market

Europe Medical Cannabis Market Analysis and Insights

Legal cannabis is one of the fastest-growing industries in European states, with major implications for food and beverage, textile, chemical, and many other industries. Hemp seeds have been used as a nutritional food for thousands of years. These seeds contain very few levels of THC (δ-9-tetrahydrocannabinol), and hence, they are different from medicinal marijuana.

Europe Medical Cannabis Market

Europe Medical Cannabis Market

Data Bridge Market Research analyzes that the medical cannabis market is expected to grow at a CAGR of 33.6% in the forecast period of 2024 to 2031 and is expected to reach USD 24,646.06 million by 2031 from USD 2,625.67 million by 2023. 

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Million

Segments Covered

Product (Oil, Dried Medial Cannabis, Medical Cannabis Capsules, Whole Flower, Ground Flower, Vape Pen, Creams & Moisturizer, and Others), Source (Synthetic and Natural), Species (Cannabis Indica, Sativa, and Hybrid), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC) /Delta-8-Tetrahydrocannabinol, and Others), Application (Pain Management, Anxiety, Muscle Spasms, Nausea, Appetite Loss, Cancer, Arthritis, Alzheimer's Disease/Migranes, Epilepsy, Depression and Sleep Disorders, Multiple Sclerosis, Autism, Mental Health Conditions, Elevate Mood, and Other), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others) End User (Pharmaceutical Industry, Research and Development Centers, Homecare Setting, Hospital, Rehab Centers, Others), Distribution Channel (B2B and B2C)

Countries Covered

Germany, France, U.K., Spain, Italy, Turkey, Netherlands, Belgium, Switzerland, Greece, Luxembourg, and Rest of Europe

Market Players Covered

Tilray, Althea Company Pty Ltd (A subsidiary of Althea Group Holdings Limited), PharmaHemp, Aurora Cannabis Inc., CANOPY GROWTH CORPORATION, Jazz Pharmaceuticals, Inc., EcoGen Biosciences, GRASS & CO., CANNARAY, and Sanity Group GmbH among others

Europe Medical Cannabis Market Definition

Cannabis is a psychoactive drug that is derived from the cannabis plant of the Cannabaceae family. For several years, it has been used medicinally. It has a wide range of applications in the treatment of various diseases, including chronic pain, cancer, depression, diabetes, arthritis, glaucoma, epilepsy, migraines, AIDS, and Alzheimer's among others.

Europe Medical Cannabis Market Dynamics

Drivers

  • Rise in the Geriatric Population

The growing geriatric population across the globe is more susceptible to chronic illness, which requires more physician visits. The steadily aging population suffers from various health conditions, including diabetes, depression, and dementia, among others. Medical cannabis has the properties to treat these diseases, and therefore, the growing population is playing a significant role.

  • Rise in Incidence of Diseases that Require the Use of Cannabis

Chronic diseases are common health conditions around the world. Globally, one in three adults suffers from chronic conditions. Neurological diseases have affected the health and quality of life of many citizens. Chronic neurological diseases such as Alzheimer's disease, cancer, inflammatory bowel disease, and epilepsy can lead to hospitalization, long-term disability, reduced quality of life, and death.

Cannabis is a generic term used to denote the several psychoactive preparations of the plant Cannabis sativa. Cannabis has been used for medicinal or recreational purposes. Since cannabinoids react with receptors in the nervous system, researchers believe cannabinoids may be helpful in treating other neurologic conditions. Medical cannabis is safe and effective for improving symptoms such as pain, sleep disorders, and anxiety due to chronic diseases in older adults.

Europe Medical Cannabis Market

Opportunities

  • Strategic Initiatives by Market Players

The need for medications to treat knee disorders in Europe has increased due to the rise in prevalence and incidence of chronic knee disorders, advanced therapies for knee osteoarthritis and meniscal injuries, and unmet medical needs. The factors (such as the rise in incidence, cases of chronic knee disorders, and availability of advanced therapies) enhance the necessity for orthopedic rehabilitation therapy, and to achieve the market demand, minor and major market players are utilizing various strategies.

  • Novel Product Development with Increasing Research and Development (R&D) Activities

Vigorous growth in the demand for cannabis with legalization has increased the need to come up with better product strains and delivery systems. This has led many companies to conduct research and development activities to check the genetic improvement strategies for cannabis.

The companies are extremely focused on developing large-yielding varieties, improved herbicide tolerance, low THC content, and better harvesting and market qualities of cannabis crops. As the strains are improved, this will lead to the production of a better quality of cannabis, and this will create more demand for good quality seeds. Hence, novel product development is expected to act as an opportunity for the market.

Restraints/Challenges

• Long Term and Short Term Side Effects Related to the Use of Cannabis and Cannabis Overuse

Orthopedic specialists observe certain risks while using the implants and consuming the medications. The knee replacement surgeries deliver complications that arise from surgery or a faulty implant. The implant becoming loose is one of the most severe complications after knee surgery, and pain is the most common one. Loosening can cause bone fractures, instability, and serious falls. Almost all serious complications require revision surgery. The risks faced are mechanical risks, knee implant loosening, and physical pain.

Marijuana is the second most commonly used psychotropic drug after alcohol. Smoking THC-rich resins, which are extracted from the cannabis plant, is on the rise, and it has caused severe emergency problems for consumers.

  • Shortage of Skilled Personnel

The cannabis industry is not only facing supply shortages, product restrictions, and stringent regulations but also the skilled personnel which is required to run the industry smoothly. The cannabis industry deals with emerging candidate concerns and the shortage of skilled personnel. From the stigma of working with previously banned substances to expertise and security, all these challenges are faced by the industry.

Recent Development

  • In May 2020, Tilray announced that it had received GMP certification by European Union standards, which allows the facility to manufacture medical cannabis extracts in-house and export finished medical cannabis products. This helped the company to expand its business
  • In February 2022, Sanity Group GmbH, a business segment of Sanity Medical, formed an agreement with the telemedicine platform Telaleaf to strengthen telemedicine in cannabis therapy in Germany

Europe Medical Cannabis Market Scope

The Europe medical cannabis market is segmented on the basis of product, source, species, derivatives, application, route of administration, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Oil
  •  Dried Medical Cannabis
  •  Medical Cannabis Capsules
  •  Vape Pen
  •  Whole Flower
  •  Creams & Moisturizer
  •  Ground Flower
  •  Others

On the basis of product, the market is segmented into oil, medical cannabis capsules, whole flower, ground flower, vape pen, dried medical cannabis, creams & moisturizer, and others.

Source

  • Natural
  • Synthetic

On the basis of source, the market is segmented into synthetic and natural.

Species

  • Sativa
  • Hybrid
  • Cannabis Indica

On the basis of species, the market is segmented into sativa, hybrid, and cannabis indica.

Derivatives

  • Cannabidiol (CBD)
  • Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol
  • Others

On the basis of derivatives, the market is segmented into Cannabidiol (CBD), Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol, and others.

Application

  • Pain Management
  • Anxiety
  •  Muscle Spasms
  •  Nausea
  •  Appetite Loss
  •  Cancer
  •  Arthritis
  •  Alzheimer's Disease/Migranes
  •  Epilepsy
  •  Depression and Sleep Disorders
  •  Multiple Sclerosis
  •  Autism
  •  Mental Health Conditions
  •  Elevate Modd
  •  Others

On the basis of application, the market is segmented into pain management, anxiety, muscle spasms, nausea, appetite loss, cancer, arthritis, alzheimer's disease/migranes, epilepsy, depression and sleep disorders, multiple sclerosis, autism, mental health conditions, elevate modd, and others.

Route of Administration

  • Oral Solution and Capsules
  • Smoking
  • Topicals
  • Vaporizers
  • Others

On the basis of route of administration, the market is segmented into oral solution and capsules, smoking, topicals, vaporizers, and others.

End User

  • Homecare Setting
  • Hospital
  • Rehab Centers
  • Pharmaceutical Industry
  • Research and Development Centers
  • Others

On the basis of end user, the market is segmented into homecare setting, hospital, rehab centers, pharmaceutical industry, research and development centers, and others.

Distribution Channel

  • B2C
  • B2B

On the basis of distribution channel, the market is segmented into B2C and B2B.

Europe Medical Cannabis Market

Europe Medical Cannabis Market: Regional Analysis/Insights

The Europe medical cannabis market is segmented on the basis of product, source, species, derivatives, application, route of administration, end user, and distribution channel.

The countries covered in the Europe medical cannabis market report are Germany, France, U.K., Spain, Italy, Turkey, Netherlands, Belgium, Switzerland, Greece, Luxembourg, and rest of Europe.

Germany is expected to dominate the market due to a rise in knee osteoarthritis, knee arthroplasty surgeries, and various orthopedic centers in Germany.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Share Analysis: Europe Medical Cannabis Market

The Europe medical cannabis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the Europe medical cannabis market.

Some of the major players operating in the Europe medical cannabis market are Tilray, Althea Company Pty Ltd (A subsidiary of Althea Group Holdings Limited), PharmaHemp, Aurora Cannabis Inc., CANOPY GROWTH CORPORATION, Jazz Pharmaceuticals, Inc., EcoGen Biosciences, GRASS & CO., CANNARAY, and Sanity Group GmbH among others.


SKU-

TABLE 1 NEUROLOGICAL CONDITIONS FOR WHICH CANNABIS-BASED TREATMENTS HAVE BEEN EMPLOYED

TABLE 2 EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 3 EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM)

TABLE 4 EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM)

TABLE 5 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 6 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 7 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 8 EUROPE DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 9 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 10 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION)

TABLE 11 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 12 EUROPE VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 13 EUROPE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 14 EUROPE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 15 EUROPE MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 16 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 17 EUROPE MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 18 EUROPE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION)

TABLE 19 EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 20 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 21 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 22 EUROPE ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 23 EUROPE MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 24 EUROPE NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 25 EUROPE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 26 EUROPE CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 27 EUROPE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 28 EUROPE ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 29 EUROPE EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 30 EUROPE DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 31 EUROPE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 32 EUROPE AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 33 EUROPE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 34 EUROPE ELEVATE MODD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 35 EUROPE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)

TABLE 36 EUROPE MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 37 EUROPE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 38 EUROPE B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 39 EUROPE MEDICAL CANNABIS MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 40 GERMANY MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 41 GERMANY MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM)

TABLE 42 GERMANY MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM)

TABLE 43 GERMANY OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 44 GERMANY OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 45 GERMANY OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 46 GERMANY DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 47 GERMANY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 48 GERMANY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION)

TABLE 49 GERMANY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 50 GERMANY VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 51 GERMANY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 52 GERMANY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 53 GERMANY MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 54 GERMANY SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 55 GERMANY MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 56 GERMANY MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION)

TABLE 57 GERMANY MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 58 GERMANY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 59 GERMANY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 60 GERMANY ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 61 GERMANY MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 62 GERMANY NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 63 GERMANY APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 64 GERMANY CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 65 GERMANY ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 66 GERMANY ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 67 GERMANY EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 68 GERMANY DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 69 GERMANY MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 70 GERMANY AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 71 GERMANY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 72 GERMANY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 73 GERMANY ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 74 GERMANY MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)

TABLE 75 GERMANY MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 76 GERMANY MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 77 GERMANY B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 78 U.K. MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 79 U.K. MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM)

TABLE 80 U.K. MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM)

TABLE 81 U.K. OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 82 U.K. OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 83 U.K. OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 84 U.K. DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 85 U.K. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 86 U.K. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION)

TABLE 87 U.K. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 88 U.K. VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 89 U.K. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 90 U.K. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 91 U.K. MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 92 U.K. SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 93 U.K. MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 94 U.K. MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION)

TABLE 95 U.K. MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 96 U.K. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 97 U.K. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 98 U.K. ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 99 U.K. MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 100 U.K. NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 101 U.K. APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 102 U.K. CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 103 U.K. ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 104 U.K. ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 105 U.K. EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 106 U.K. DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 107 U.K. MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 108 U.K. AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 109 U.K. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 110 U.K. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 111 U.K. ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 112 U.K. MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)

TABLE 113 U.K. MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 114 U.K. MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 115 U.K. B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 116 ITALY MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 117 ITALY MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM)

TABLE 118 ITALY MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM)

TABLE 119 ITALY OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 120 ITALY OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 121 ITALY OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 122 ITALY DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 123 ITALY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 124 ITALY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION)

TABLE 125 ITALY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 126 ITALY VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 127 ITALY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 128 ITALY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 129 ITALY MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 130 ITALY SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 131 ITALY MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 132 ITALY MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION)

TABLE 133 ITALY MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 134 ITALY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 135 ITALY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 136 ITALY ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 137 ITALY MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 138 ITALY NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 139 ITALY APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 140 ITALY CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 141 ITALY ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 142 ITALY ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 143 ITALY EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 144 ITALY DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 145 ITALY MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 146 ITALY AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 147 ITALY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 148 ITALY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 149 ITALY ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 150 ITALY MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)

TABLE 151 ITALY MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 152 ITALY MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 153 ITALY B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 154 NETHERLANDS MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 155 NETHERLANDS MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM)

TABLE 156 NETHERLANDS MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM)

TABLE 157 NETHERLANDS OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 158 NETHERLANDS OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 159 NETHERLANDS OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 160 NETHERLANDS DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 161 NETHERLANDS MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 162 NETHERLANDS MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION)

TABLE 163 NETHERLANDS MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 164 NETHERLANDS VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 165 NETHERLANDS WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 166 NETHERLANDS GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 167 NETHERLANDS MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 168 NETHERLANDS SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 169 NETHERLANDS MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 170 NETHERLANDS MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION)

TABLE 171 NETHERLANDS MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 172 NETHERLANDS PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 173 NETHERLANDS PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 174 NETHERLANDS ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 175 NETHERLANDS MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 176 NETHERLANDS NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 177 NETHERLANDS APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 178 NETHERLANDS CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 179 NETHERLANDS ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 180 NETHERLANDS ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 181 NETHERLANDS EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 182 NETHERLANDS DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 183 NETHERLANDS MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 184 NETHERLANDS AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 185 NETHERLANDS MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 186 NETHERLANDS MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 187 NETHERLANDS ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 188 NETHERLANDS MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)

TABLE 189 NETHERLANDS MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 190 NETHERLANDS MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 191 NETHERLANDS B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 192 SWITZERLAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 193 SWITZERLAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM)

TABLE 194 SWITZERLAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM)

TABLE 195 SWITZERLAND OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 196 SWITZERLAND OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 197 SWITZERLAND OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 198 SWITZERLAND DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 199 SWITZERLAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 200 SWITZERLAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION)

TABLE 201 SWITZERLAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 202 SWITZERLAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 203 SWITZERLAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 204 SWITZERLAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 205 SWITZERLAND MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 206 SWITZERLAND SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 207 SWITZERLAND MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 208 SWITZERLAND MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION)

TABLE 209 SWITZERLAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 210 SWITZERLAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 211 SWITZERLAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 212 SWITZERLAND ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 213 SWITZERLAND MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 214 SWITZERLAND NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 215 SWITZERLAND APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 216 SWITZERLAND CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 217 SWITZERLAND ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 218 SWITZERLAND ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 219 SWITZERLAND EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 220 SWITZERLAND DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 221 SWITZERLAND MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 222 SWITZERLAND AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 223 SWITZERLAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 224 SWITZERLAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 225 SWITZERLAND ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 226 SWITZERLAND MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)

TABLE 227 SWITZERLAND MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 228 SWITZERLAND MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 229 SWITZERLAND B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 230 FRANCE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 231 FRANCE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM)

TABLE 232 FRANCE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM)

TABLE 233 FRANCE OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 234 FRANCE OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 235 FRANCE OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 236 FRANCE DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 237 FRANCE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 238 FRANCE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION)

TABLE 239 FRANCE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 240 FRANCE VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 241 FRANCE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 242 FRANCE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 243 FRANCE MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 244 FRANCE SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 245 FRANCE MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 246 FRANCE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION)

TABLE 247 FRANCE MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 248 FRANCE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 249 FRANCE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 250 FRANCE ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 251 FRANCE MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 252 FRANCE NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 253 FRANCE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 254 FRANCE CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 255 FRANCE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 256 FRANCE ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 257 FRANCE EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 258 FRANCE DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 259 FRANCE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 260 FRANCE AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 261 FRANCE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 262 FRANCE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 263 FRANCE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 264 FRANCE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)

TABLE 265 FRANCE MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 266 FRANCE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 267 FRANCE B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 268 RUSSIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 269 RUSSIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM)

TABLE 270 RUSSIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM)

TABLE 271 RUSSIA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 272 RUSSIA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 273 RUSSIA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 274 RUSSIA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 275 RUSSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 276 RUSSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION)

TABLE 277 RUSSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 278 RUSSIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 279 RUSSIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 280 RUSSIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 281 RUSSIA MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 282 RUSSIA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 283 RUSSIA MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 284 RUSSIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION)

TABLE 285 RUSSIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 286 RUSSIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 287 RUSSIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 288 RUSSIA ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 289 RUSSIA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 290 RUSSIA NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 291 RUSSIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 292 RUSSIA CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 293 RUSSIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 294 RUSSIA ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 295 RUSSIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 296 RUSSIA DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 297 RUSSIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 298 RUSSIA AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 299 RUSSIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 300 RUSSIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 301 RUSSIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 302 RUSSIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)

TABLE 303 RUSSIA MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 304 RUSSIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 305 RUSSIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 306 SPAIN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 307 SPAIN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM)

TABLE 308 SPAIN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM)

TABLE 309 SPAIN OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 310 SPAIN OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 311 SPAIN OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 312 SPAIN DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 313 SPAIN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 314 SPAIN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION)

TABLE 315 SPAIN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 316 SPAIN VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 317 SPAIN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 318 SPAIN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 319 SPAIN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 320 SPAIN SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 321 SPAIN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 322 SPAIN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION)

TABLE 323 SPAIN MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 324 SPAIN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 325 SPAIN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 326 SPAIN ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 327 SPAIN MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 328 SPAIN NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 329 SPAIN APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 330 SPAIN CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 331 SPAIN ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 332 SPAIN ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 333 SPAIN EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 334 SPAIN DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 335 SPAIN MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 336 SPAIN AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 337 SPAIN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 338 SPAIN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 339 SPAIN ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 340 SPAIN MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)

TABLE 341 SPAIN MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 342 SPAIN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 343 SPAIN B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 344 BELGIUM MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 345 BELGIUM MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM)

TABLE 346 BELGIUM MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM)

TABLE 347 BELGIUM OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 348 BELGIUM OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 349 BELGIUM OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 350 BELGIUM DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 351 BELGIUM MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 352 BELGIUM MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION)

TABLE 353 BELGIUM MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 354 BELGIUM VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 355 BELGIUM WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 356 BELGIUM GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 357 BELGIUM MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 358 BELGIUM SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 359 BELGIUM MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 360 BELGIUM MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION)

TABLE 361 BELGIUM MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 362 BELGIUM PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 363 BELGIUM PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 364 BELGIUM ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 365 BELGIUM MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 366 BELGIUM NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 367 BELGIUM APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 368 BELGIUM CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 369 BELGIUM ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 370 BELGIUM ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 371 BELGIUM EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 372 BELGIUM DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 373 BELGIUM MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 374 BELGIUM AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 375 BELGIUM MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 376 BELGIUM MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 377 BELGIUM ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 378 BELGIUM MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)

TABLE 379 BELGIUM MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 380 BELGIUM MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 381 BELGIUM B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 382 GREECE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 383 GREECE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM)

TABLE 384 GREECE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM)

TABLE 385 GREECE OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 386 GREECE OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 387 GREECE OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 388 GREECE DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 389 GREECE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 390 GREECE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION)

TABLE 391 GREECE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 392 GREECE VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 393 GREECE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 394 GREECE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 395 GREECE MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 396 GREECE SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 397 GREECE MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 398 GREECE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION)

TABLE 399 GREECE MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 400 GREECE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 401 GREECE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 402 GREECE ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 403 GREECE MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 404 GREECE NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 405 GREECE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 406 GREECE CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 407 GREECE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 408 GREECE ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 409 GREECE EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 410 GREECE DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 411 GREECE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 412 GREECE AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 413 GREECE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 414 GREECE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 415 GREECE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 416 GREECE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)

TABLE 417 GREECE MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 418 GREECE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 419 GREECE B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 420 LUXEMBOURG MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 421 LUXEMBOURG MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM)

TABLE 422 LUXEMBOURG MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM)

TABLE 423 LUXEMBOURG OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 424 LUXEMBOURG OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 425 LUXEMBOURG OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 426 LUXEMBOURG DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 427 LUXEMBOURG MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 428 LUXEMBOURG MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION)

TABLE 429 LUXEMBOURG MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 430 LUXEMBOURG VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 431 LUXEMBOURG WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 432 LUXEMBOURG GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 433 LUXEMBOURG MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION)

TABLE 434 LUXEMBOURG SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 435 LUXEMBOURG MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION)

TABLE 436 LUXEMBOURG MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION)

TABLE 437 LUXEMBOURG MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 438 LUXEMBOURG PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 439 LUXEMBOURG PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 440 LUXEMBOURG ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 441 LUXEMBOURG MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 442 LUXEMBOURG NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 443 LUXEMBOURG APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 444 LUXEMBOURG CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 445 LUXEMBOURG ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 446 LUXEMBOURG ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 447 LUXEMBOURG EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 448 LUXEMBOURG DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 449 LUXEMBOURG MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 450 LUXEMBOURG AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 451 LUXEMBOURG MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 452 LUXEMBOURG MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 453 LUXEMBOURG ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 454 LUXEMBOURG MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)

TABLE 455 LUXEMBOURG MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 456 LUXEMBOURG MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 457 LUXEMBOURG B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 458 REST OF EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION)

TABLE 459 REST OF EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM)

TABLE 460 REST OF EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Medical Cannabis Market size will be worth USD 24,646.06 million by 2031 during the forecast period.
The Medical Cannabis Market growth rate is 33.6% during the forecast period.
The Rise in the Geriatric Population and Rise in Incidence of Diseases that Require the Use of Cannabis are the growth drivers of the Europe Medical Cannabis Market.
The product, source, species, derivatives, application, route of administration, end user, and distribution channel are the factors on which the Europe Medical Cannabis Market research is based.
The major companies in the Europe Medical Cannabis Market are Tilray, Althea Company Pty Ltd (A subsidiary of Althea Group Holdings Limited), PharmaHemp, Aurora Cannabis Inc., CANOPY GROWTH CORPORATION, Jazz Pharmaceuticals, Inc., EcoGen Biosciences, GRASS & CO., CANNARAY, and Sanity Group GmbH.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials